Peer Review History
| Original SubmissionMarch 4, 2023 |
|---|
|
PONE-D-23-06211Archetypal analysis of COVID-19 in Montana, USA, March 13, 2020 to April 26, 2022PLOS ONE Dear Dr. Stone, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I strongly encourage the authors to address all the issues raised by both the reviewers. In particular, given your statement about the use of data publicly avaialble, I encourage you to share you data and code to allow a thorough check of the paper's analysis for the revision. Please submit your revised manuscript by Jul 23 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Maurizio Fiaschetti Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health (NIH), United States [Award Number P20GM130418]. We thank the anonymous reviewers for offering feedback on manuscript. We also thank he Montana Department of Public Health and Human Services, Communicable Disease Epidemiology Section, for allowing us access to Montana’s COVID-19 data. " We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "EL: This research was supported by the National Institute of General Medical Sciences of 428 the National Institutes of Health (NIH), United States [Award Number P20GM130418] nigms.nih.gov The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ. 5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 6. We note that Figures 3a to 3j, 8a to 8h, 13a to 13e in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figures 3a to 3j, 8a to 8h, 13a to 13e to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper describes an application of the archetypal analysis to study of COVID-19 epidemic in the state of Montana. While the application by itself is interesting from the methodological perspective, the manuscript has several important drawbacks: 1) The authors have not provided access to their data and code. This violates the community standards for data availability, which stipulates that data and code should be accessible to reviewers and readers of the paper for validation purposes. 2) The results are not clearly formulated, rendering the central message of the study unclear. The authors did not supply any quantitative or statistical evidence to substantiate the associations described in the Results section. 3) The rationale behind the abrupt shift from discussing COVID-19 pandemic results to flu on page 10 is unclear, as is the relevance of flu to the overall topic of the paper. 4) It is unclear why a significant portion of the results section (pages 5-6) is devoted to results acknowledged by the authors to be biased. 5) The decision to select 10 archetypes for the analysis (as stated on page 5) lacks a clear justification. 6) The paper is not well-written. For instance, the first paragraph of the introduction leaves readers questioning the essence of the "new implementations" that rendered spatio-temporal approaches tractable (implementations of what?), why these approaches were previously intractable, and the nature of the "patterns over time" mentioned. Furthermore, the sentence "the methods can detect spatial clustering could may reveal environmental causatives" is particularly opaque. 7) Table 1 is not cited in the paper. Reviewer #2: The authors apply archival analysis (AA), an innovative tool similar to principal components analysis (PCA). The rationale for applying AA is convincing and the results are interesting. Major Comment: The subsection on the mathematical formulation has some problems. I believe these problems are in the explanation, not in any underlying issue with the method itself. The authors say “Given a specified value for k, AA identifies m-dimensional vectors z_1, z_2, … , z_k that best describe k characteristic patterns, or archetypes in the original data set … .” They go on to give some restrictions regarding these z’s, but they don’t say precisely what “best” means. The authors seem to make an attempt to make things precise at the bottom of p. 3 where they say “The m x k matrix Z of k archetypes is defined by the matrix factorization problem: min_{A,B} || X – XBA || where Z = XB.” A couple of remarks on this statement. First, the authors don’t exactly say what the matrix factorization problem is. It actually looks like a minimization problem, not a matrix factorization problem. Is Z the minimum of || X – XBA || over all A and B? If so, they could write Z = arg min_{A,B} || X – XBA ||. I see no connection between Z and the minimization problem. Second, at the end of the sentence, they say Z = XB. So is Z the solution to the given minimization problem, or is it simply XB? Minor Comments 1. The authors often talk about “observations” when they really mean “days.” It would help the reader to say there are data values for counties and days. Every time I saw “observations” I had to stop reading and think about what that means. 2. Near the bottom of p. 2, the authors talk about the AA algorithm. At this point of the paper, I didn’t have enough background to understand what any of this means. I’d suggest trimming this back, and then coming back to it later in the paper once the groundwork is laid. 3. It looks like the authors used Matlab, a package familiar to most mathematicians. Statisticians tend to use R because of its array of functions for doing data analysis. I believe there is an R package to do AA, which is called "archetypes". See the paper Eugster, M., & Leisch, F. (2009). From spider-man to hero-archetypal analysis in R. https://cran.r-project.org/web/packages/archetypes/vignettes/archetypes.pdf 4. On p. 3, first paragraph, the authors say “To account for differences in population size, we weighted the COVID-19 cases … .” “Weighted” could mean a lot of things in this context. Did the authors just look COVID rates on a per capita basis? 5. p. 3, just above equation (1). Should be “… coefficients that sum to unity …” 6. In equation (1) and thereafter, the betas are vectors and should be bold. This can be easily done in LaTeX using the amsmath package and the \\boldsymbol{} command. 7. p. 3, just after equation (1), Should be “Each archetype is either a convex combination of …” 8 p. 3, lines 84 and 90 (using numbering in the right margin). Write these matrices using brackets: B = [ beta_1, … , beta_k ] and A = [ alpha_1 , … , alpha_n ]. These alphas and betas are themselves vectors and should be bold. Also use \\ldots for the ellipsis between commas; save \\cdots for the ellipsis between math operators like “+”. 9. In equation (1), the constraints must hold for all j. The “for all j” could be added a the end of (1). 10. The definition of mutual information at the bottom of p. 4 looked asymmetric to me. I got out some paper and tried to see whether it was symmetric, and of course it is. Then I turned the page and saw that the authors pointed out the symmetry. By the way, the description of MI at the top of p. 5 is very nice! 11. I couldn’t help but think that ten archetypes may be a bit much. I suspect that by the time you get past the first five or six, you get mostly noise. I’m not suggesting anything specific here, except maybe a statement that there will come a point beyond which we are observing noise. 12. p. 8, line 221. Shouldn’t “no flu” be “no COVID”? Same page, line 228, shouldn’t figure 8 be “Fig. 8”? 13. Throughout, I’d suggest not spelling out alpha. Just use $\\alpha$. 14. p. 13, lines 355-357. “A high (relative) MI indicates that a county’s time series can be better predicted by considering the other, and vice versa.” First, congratulations on getting “vice versa” correct; I always put a hyphen between the words, which is incorrect. I think the idea is that you can augment data from a county with other counties for which the MI is high. The way it is worded suggests that you ignore the data from the current county and just use the data from counties with a high MI. 15. The graphs are generally fuzzy. I know that PLOS ONE allows files in TIFF or EPS format only. EPS is a vector graphics format so the figures should be clear (no fuzziness at any level of magnification). I suspect the authors used TIFF files. The best strategy would be to render the graphs in EPS format. If this isn’t possible, then maybe saving the files at a higher TIFF resolution would make them clear. 16. In Figure 3, the axes are not needed. The legend on the right is, however, needed, but this can be given once (assuming the legend is the same for all archetypes). The figure will probably be set in a 5 by 2 array of maps so it fits on one page. The county names will not be readable at this scale. Similar comments apply to Figure 8. If the county names are needed, the authors might consider giving one map of Montana with just the county names. This figure could contain the map information (e.g., compass, scale in miles, surrounding topography, etc.) along with the county names. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Archetypal analysis of COVID-19 in Montana, USA, March 13, 2020 to April 26, 2022 PONE-D-23-06211R1 Dear Dr. Stone, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Maurizio Fiaschetti Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: No Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) Reviewer #3: The present study is interesting because it analyzes Archetypal to epidemiological data of COVID-19 from March 13, 2020 to April 26, 2022, for the counties of Montana, USA. The manuscript has already undergone an extensive review, with many details that have actually made the manuscript substantially improve its quality. The authors made the suggested adjustments appropriately and the manuscript can be accepted for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Steven E. Rigdon Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-23-06211R1 Archetypal analysis of COVID-19 in Montana, USA, March 13, 2020 to April 26, 2022 Dear Dr. Stone: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Maurizio Fiaschetti Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .